Interleukin-35 expression protects against cigarette smoke-induced lung inflammation in mice - 06/01/19
pages | 6 |
Iconographies | 4 |
Vidéos | 0 |
Autres | 0 |
Highlights |
• | IL-35 inhibits cigarette smoke-induced airway inflammation. |
• | IL-35 reduces cigarette smoke-induced inflammatory cytokines production. |
• | IL-35 increases anti-inflammatory cytokine IL-10 production in mice. |
Abstract |
Cigarette smoke (CS) is a very important cause of pulmonary inflammatory diseases. Interleukin (IL)-35 is a novel anti-inflammatory cytokine but its role in CS-mediated lung inflammation remains unclear. In the present study, we examined the effect of IL-35 expression on CS-induced lung inflammation in mice. A plasmid DNA expressing IL-35 was injected into mice via a hydrodynamic-based gene delivery that were subsequently exposed to CS three times a day for 5 days. We found that IL-35 expression inhibited pulmonary inflammatory infiltration, lung tissue lesions, mucus secretion, and myeloperoxidase activity in CS-treated mice. Moreover, IL-35 expression decreased the production of IL-1β, tumor necrosis factor-α, IL-6, and IL-17, but increased the level of IL-10 in bronchoalveolar lavage fluids and lung tissues from CS-challenged mice. These results suggest that in vivo expression of IL-35 can protect against CS-induced lung inflammation and may be a therapeutic target in CS-related pulmonary diseases.
Le texte complet de cet article est disponible en PDF.Keywords : IL-35, Hydrodynamic-based gene delivery, Cigarette smoke, Lung inflammation
Plan
Vol 110
P. 727-732 - février 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?